Compare FLGT & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLGT | CIM |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.4M | 1.0B |
| IPO Year | 2016 | 2007 |
| Metric | FLGT | CIM |
|---|---|---|
| Price | $28.05 | $13.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $28.33 | $15.25 |
| AVG Volume (30 Days) | 205.0K | ★ 858.8K |
| Earning Date | 02-27-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 11.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $315,549,000.00 | $191,573,000.00 |
| Revenue This Year | $16.84 | $11.44 |
| Revenue Next Year | $9.74 | $21.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.61 | N/A |
| 52 Week Low | $14.57 | $9.85 |
| 52 Week High | $31.04 | $15.37 |
| Indicator | FLGT | CIM |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 57.53 |
| Support Level | $27.56 | $12.27 |
| Resistance Level | $28.44 | $13.19 |
| Average True Range (ATR) | 0.71 | 0.27 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 82.51 | 88.24 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.